Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Cardiovascular Drugs and Therapy|August 9, 2020
Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic CardiomyopathyYumei Ye, Yochai Birnbaum, Steven G Widen, et al.
Diabetes & Vascular Disease Research|January 24, 2017
Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemiaYan Chen, Hongmei Chen, Yochai Birnbaum, et al.
Diabetes|September 28, 2002
Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetesMandeep Bajaj, Thongchai Pratipanawatr, Rachele Berria, et al.
Basic Research in Cardiology|May 3, 2013
Dickkopf-1 (DKK1) phosphatase and tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA interference in the diabetic heartShukuan Ling, Yochai Birnbaum, Manjyot K Nanhwan, et al.
Diabetes|October 27, 2005
Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patientsMandeep Bajaj, Swangjit Suraamornkul, Anthony Romanelli, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 12, 2002
Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humansMandeep Bajaj, Rachele Berria, Thongchai Pratipanawatr, et al.
Endocrinology|August 18, 2011
NF-kappaB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: blockade by adiponectinSanjeev Choudhary, Sandeep Sinha, Yanhua Zhao, et al.
Cardiovascular Drugs and Therapy|September 1, 2012
Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitusYochai Birnbaum, Alexander C Castillo, Jinqiao Qian, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 30, 2012
Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetesYumei Ye, Jinqiao Qian, Alexander C Castillo, et al.
Diabetes Care|December 2, 2024
Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes AssociationJoshua J Neumiller, Mandeep Bajaj, Raveendhara R Bannuru, et al.
Pageof 6